Ground News

News from pharmtech.com

All of today’s top news stories from pharmtech.com. Get the full analysis behind how media bias impacts breaking news.

Overall, we’ve indexed 152 stories from pharmtech.com over the past 3 months.

We’ve assigned a media bias rating of to pharmtech.com. You can read more about our methodology here.

If you want to know if pharmtech.com is credible or reliable, look no further. We rank pharmtech.com as Unknown factuality. Find out more about our methodology here.

Information about pharmtech.com

Where is pharmtech.com located?pharmtech.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top pharmtech.com News

Research

UPSHER-SMITH TO SHOWCASE RARE DISEASE PORTFOLIO AT 2025 AAN ANNUAL MEETING

80% Center coverage: 5 sources

Company to Feature First and Only Ready-to-Use Liquid Vigabatrin at Booth #846See the Story

FDA · Rockville

Makary’s first speech to FDA staff focuses on challenging norms, fighting chronic disease

100% Center coverage: 1 sources

WASHINGTON — Marty Makary’s first address to staff as FDA commissioner on Wednesday afternoon sounded a bit like an introduction to one of his books. It included sweeping declarations about the need to challenge scientific norms, and to identify the root causes of chronic disease. Makary sprinkled in anecdotes intended to stir emotion, recounting the time when his father gave a cancer patient a hug at the grocery store. But he said little abou…See the Story

Extractable and Leachable Challenges in Lyophilized Drug Products

The authors examine the risks of extractables and leachables, and present solutions that emphasize the importance of a strategic, multi-prong approach.See the Story

News from pharmtech.com